- Home
- CTNT vs BDRX Comparison
CTNT vs BDRX Comparison
Compare CTNT & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTNT
- BDRX
- Stock Information
- Founded
- CTNT 2016
- BDRX 2000
- Country
- CTNT United States
- BDRX United Kingdom
- Employees
- CTNT N/A
- BDRX N/A
- Industry
- CTNT
- BDRX Biotechnology: Pharmaceutical Preparations
- Sector
- CTNT
- BDRX Health Care
- Exchange
- CTNT Nasdaq
- BDRX Nasdaq
- Market Cap
- CTNT 5.0M
- BDRX 5.8M
- IPO Year
- CTNT 2023
- BDRX N/A
- Fundamental
- Price
- CTNT $1.34
- BDRX $0.87
- Analyst Decision
- CTNT
- BDRX
- Analyst Count
- CTNT 0
- BDRX 0
- Target Price
- CTNT N/A
- BDRX N/A
- AVG Volume (30 Days)
- CTNT 1.7M
- BDRX 3.1M
- Earning Date
- CTNT 08-12-2025
- BDRX 04-11-2025
- Dividend Yield
- CTNT N/A
- BDRX N/A
- EPS Growth
- CTNT N/A
- BDRX N/A
- EPS
- CTNT N/A
- BDRX N/A
- Revenue
- CTNT $858,770.00
- BDRX N/A
- Revenue This Year
- CTNT $302.80
- BDRX N/A
- Revenue Next Year
- CTNT $22.22
- BDRX N/A
- P/E Ratio
- CTNT N/A
- BDRX N/A
- Revenue Growth
- CTNT N/A
- BDRX N/A
- 52 Week Low
- CTNT $1.12
- BDRX $0.78
- 52 Week High
- CTNT $9.71
- BDRX $41.50
- Technical
- Relative Strength Index (RSI)
- CTNT 48.43
- BDRX 37.29
- Support Level
- CTNT $1.12
- BDRX $0.83
- Resistance Level
- CTNT $1.38
- BDRX $0.90
- Average True Range (ATR)
- CTNT 0.09
- BDRX 0.10
- MACD
- CTNT 0.01
- BDRX 0.00
- Stochastic Oscillator
- CTNT 76.79
- BDRX 17.62
About CTNT Cheetah Net Supply Chain Service Inc.
Cheetah Net Supply Chain Service Inc is a one-stop services including Warehousing, Logistics, International trading & Supply Chain Finance, Etc. It operate in single segment Logistics and warehousing services which focuses on providing freight forwarding services for clients shipping goods from the U.S. to mainland China or Hong Kong. Its services include: (i) cargo storage, (ii) freight forwarding, (iii) U.S. customs clearance, and (iv) labor services and cargo loading and unloading.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.